Showing results (21-30 of 223) with videos related to
Sort By:
Pageof 23
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 13, 2007
NF-kappaB-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2ABéatrice Benayoun, Stephen Baghdiguian, Alicia Lajmanovich, et al.Revue De L'Infirmiere|February 6, 2013
[Emergency admission to a palliative care unit]Isabelle RichardArchives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 3, 2023
Basic notions about gene therapy from the nucleic acid perspective and applications in a pediatric disease: Duchenne muscular dystrophyIsabelle RichardMuscle & Nerve|July 22, 2014
Exome sequencing as a second-tier diagnostic approach for clinically suspected dysferlinopathy patientsMarc Bartoli, Jean-Pierre Desvignes, Levy Nicolas, et al.Plos One|June 6, 2012
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathyWilliam Lostal, Marc Bartoli, Carinne Roudaut, et al.Genetic Testing and Molecular Biomarkers|November 26, 2009
Exclusion of mutations in the dysferlin alternative exons 1 of DYSF-v1, 5a, and 40a in a cohort of 26 patientsMartin Krahn, Véronique Labelle, Ana Borges, et al.Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Dysferlin Exon 32 Skipping in Patient CellsFlorian Barthélémy, Sébastien Courrier, Nicolas Lévy, et al.Journal of Neuromuscular Diseases|February 27, 2018
Muscle Cells Fix Breaches by Orchestrating a Membrane Repair BalletFlorian Barthélémy, Aurélia Defour, Nicolas Lévy, et al.Scientific Reports|May 16, 2024
System-level analysis of genes mutated in muscular dystrophies reveals a functional pattern associated with muscle weakness distributionOzan Ozisik, Svetlana Gorokhova, Mathieu Cerino, et al.Molecular Medicine (Cambridge, Mass.)|May 11, 2011
Translational research and therapeutic perspectives in dysferlinopathiesFlorian Barthélémy, Nicolas Wein, Martin Krahn, et al.Pageof 23